Artificial Organs Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Artificial Organs Market Size Analysis

Global Artificial Organs Market Introduction
By Organ Type
1. Introduction
  1. Organ Type By Value
2. Artificial Heart
  1. By Value
  2. Prosthetic Heart Valves
    1. Prosthetic Heart Valves By Value
  3. Ventricular Assist Devices
    1. Ventricular Assist Devices By Value
  4. Cardiac Pacemakers & ICDs
    1. Cardiac Pacemakers & ICDs By Value
3. Artificial Kidney
  1. By Value
4. Artificial Pancreas
  1. By Value
5. Artificial Lungs/ECMO
  1. By Value
6. Cochlear & Auditory Brain-stem Implants
  1. By Value
7. Bio-artificial Liver
  1. By Value
8. Other Organ Types
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Mechanical
  1. By Value
3. Electronic/Bionics
  1. By Value
4. Wearable/Externally Worn
  1. By Value
5. 3D-bioprinted Constructs
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgical Centers
  1. By Value
4. Other End Users
  1. By Value

North America Market Analysis

Introduction
By Organ Type
1. Introduction
  1. Organ Type By Value
2. Artificial Heart
  1. By Value
  2. Prosthetic Heart Valves
    1. Prosthetic Heart Valves By Value
  3. Ventricular Assist Devices
    1. Ventricular Assist Devices By Value
  4. Cardiac Pacemakers & ICDs
    1. Cardiac Pacemakers & ICDs By Value
3. Artificial Kidney
  1. By Value
4. Artificial Pancreas
  1. By Value
5. Artificial Lungs/ECMO
  1. By Value
6. Cochlear & Auditory Brain-stem Implants
  1. By Value
7. Bio-artificial Liver
  1. By Value
8. Other Organ Types
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Mechanical
  1. By Value
3. Electronic/Bionics
  1. By Value
4. Wearable/Externally Worn
  1. By Value
5. 3D-bioprinted Constructs
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgical Centers
  1. By Value
4. Other End Users
  1. By Value
U.S.
1. By Organ Type
  1. Introduction
    1. Organ Type By Value
  2. Artificial Heart
    1. By Value
    2. Prosthetic Heart Valves
      1. Prosthetic Heart Valves By Value
    3. Ventricular Assist Devices
      1. Ventricular Assist Devices By Value
    4. Cardiac Pacemakers & ICDs
      1. Cardiac Pacemakers & ICDs By Value
  3. Artificial Kidney
    1. By Value
  4. Artificial Pancreas
    1. By Value
  5. Artificial Lungs/ECMO
    1. By Value
  6. Cochlear & Auditory Brain-stem Implants
    1. By Value
  7. Bio-artificial Liver
    1. By Value
  8. Other Organ Types
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Mechanical
    1. By Value
  3. Electronic/Bionics
    1. By Value
  4. Wearable/Externally Worn
    1. By Value
  5. 3D-bioprinted Constructs
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals
    1. By Value
  3. Ambulatory Surgical Centers
    1. By Value
  4. Other End Users
    1. By Value
Canada

Europe Market Analysis

Introduction
By Organ Type
1. Introduction
  1. Organ Type By Value
2. Artificial Heart
  1. By Value
  2. Prosthetic Heart Valves
    1. Prosthetic Heart Valves By Value
  3. Ventricular Assist Devices
    1. Ventricular Assist Devices By Value
  4. Cardiac Pacemakers & ICDs
    1. Cardiac Pacemakers & ICDs By Value
3. Artificial Kidney
  1. By Value
4. Artificial Pancreas
  1. By Value
5. Artificial Lungs/ECMO
  1. By Value
6. Cochlear & Auditory Brain-stem Implants
  1. By Value
7. Bio-artificial Liver
  1. By Value
8. Other Organ Types
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Mechanical
  1. By Value
3. Electronic/Bionics
  1. By Value
4. Wearable/Externally Worn
  1. By Value
5. 3D-bioprinted Constructs
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgical Centers
  1. By Value
4. Other End Users
  1. By Value
U.K.
1. By Organ Type
  1. Introduction
    1. Organ Type By Value
  2. Artificial Heart
    1. By Value
    2. Prosthetic Heart Valves
      1. Prosthetic Heart Valves By Value
    3. Ventricular Assist Devices
      1. Ventricular Assist Devices By Value
    4. Cardiac Pacemakers & ICDs
      1. Cardiac Pacemakers & ICDs By Value
  3. Artificial Kidney
    1. By Value
  4. Artificial Pancreas
    1. By Value
  5. Artificial Lungs/ECMO
    1. By Value
  6. Cochlear & Auditory Brain-stem Implants
    1. By Value
  7. Bio-artificial Liver
    1. By Value
  8. Other Organ Types
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Mechanical
    1. By Value
  3. Electronic/Bionics
    1. By Value
  4. Wearable/Externally Worn
    1. By Value
  5. 3D-bioprinted Constructs
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals
    1. By Value
  3. Ambulatory Surgical Centers
    1. By Value
  4. Other End Users
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Organ Type
1. Introduction
  1. Organ Type By Value
2. Artificial Heart
  1. By Value
  2. Prosthetic Heart Valves
    1. Prosthetic Heart Valves By Value
  3. Ventricular Assist Devices
    1. Ventricular Assist Devices By Value
  4. Cardiac Pacemakers & ICDs
    1. Cardiac Pacemakers & ICDs By Value
3. Artificial Kidney
  1. By Value
4. Artificial Pancreas
  1. By Value
5. Artificial Lungs/ECMO
  1. By Value
6. Cochlear & Auditory Brain-stem Implants
  1. By Value
7. Bio-artificial Liver
  1. By Value
8. Other Organ Types
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Mechanical
  1. By Value
3. Electronic/Bionics
  1. By Value
4. Wearable/Externally Worn
  1. By Value
5. 3D-bioprinted Constructs
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgical Centers
  1. By Value
4. Other End Users
  1. By Value
China
1. By Organ Type
  1. Introduction
    1. Organ Type By Value
  2. Artificial Heart
    1. By Value
    2. Prosthetic Heart Valves
      1. Prosthetic Heart Valves By Value
    3. Ventricular Assist Devices
      1. Ventricular Assist Devices By Value
    4. Cardiac Pacemakers & ICDs
      1. Cardiac Pacemakers & ICDs By Value
  3. Artificial Kidney
    1. By Value
  4. Artificial Pancreas
    1. By Value
  5. Artificial Lungs/ECMO
    1. By Value
  6. Cochlear & Auditory Brain-stem Implants
    1. By Value
  7. Bio-artificial Liver
    1. By Value
  8. Other Organ Types
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Mechanical
    1. By Value
  3. Electronic/Bionics
    1. By Value
  4. Wearable/Externally Worn
    1. By Value
  5. 3D-bioprinted Constructs
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals
    1. By Value
  3. Ambulatory Surgical Centers
    1. By Value
  4. Other End Users
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Organ Type
1. Introduction
  1. Organ Type By Value
2. Artificial Heart
  1. By Value
  2. Prosthetic Heart Valves
    1. Prosthetic Heart Valves By Value
  3. Ventricular Assist Devices
    1. Ventricular Assist Devices By Value
  4. Cardiac Pacemakers & ICDs
    1. Cardiac Pacemakers & ICDs By Value
3. Artificial Kidney
  1. By Value
4. Artificial Pancreas
  1. By Value
5. Artificial Lungs/ECMO
  1. By Value
6. Cochlear & Auditory Brain-stem Implants
  1. By Value
7. Bio-artificial Liver
  1. By Value
8. Other Organ Types
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Mechanical
  1. By Value
3. Electronic/Bionics
  1. By Value
4. Wearable/Externally Worn
  1. By Value
5. 3D-bioprinted Constructs
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgical Centers
  1. By Value
4. Other End Users
  1. By Value
UAE
1. By Organ Type
  1. Introduction
    1. Organ Type By Value
  2. Artificial Heart
    1. By Value
    2. Prosthetic Heart Valves
      1. Prosthetic Heart Valves By Value
    3. Ventricular Assist Devices
      1. Ventricular Assist Devices By Value
    4. Cardiac Pacemakers & ICDs
      1. Cardiac Pacemakers & ICDs By Value
  3. Artificial Kidney
    1. By Value
  4. Artificial Pancreas
    1. By Value
  5. Artificial Lungs/ECMO
    1. By Value
  6. Cochlear & Auditory Brain-stem Implants
    1. By Value
  7. Bio-artificial Liver
    1. By Value
  8. Other Organ Types
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Mechanical
    1. By Value
  3. Electronic/Bionics
    1. By Value
  4. Wearable/Externally Worn
    1. By Value
  5. 3D-bioprinted Constructs
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals
    1. By Value
  3. Ambulatory Surgical Centers
    1. By Value
  4. Other End Users
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Organ Type
1. Introduction
  1. Organ Type By Value
2. Artificial Heart
  1. By Value
  2. Prosthetic Heart Valves
    1. Prosthetic Heart Valves By Value
  3. Ventricular Assist Devices
    1. Ventricular Assist Devices By Value
  4. Cardiac Pacemakers & ICDs
    1. Cardiac Pacemakers & ICDs By Value
3. Artificial Kidney
  1. By Value
4. Artificial Pancreas
  1. By Value
5. Artificial Lungs/ECMO
  1. By Value
6. Cochlear & Auditory Brain-stem Implants
  1. By Value
7. Bio-artificial Liver
  1. By Value
8. Other Organ Types
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Mechanical
  1. By Value
3. Electronic/Bionics
  1. By Value
4. Wearable/Externally Worn
  1. By Value
5. 3D-bioprinted Constructs
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Hospitals
  1. By Value
3. Ambulatory Surgical Centers
  1. By Value
4. Other End Users
  1. By Value
Brazil
1. By Organ Type
  1. Introduction
    1. Organ Type By Value
  2. Artificial Heart
    1. By Value
    2. Prosthetic Heart Valves
      1. Prosthetic Heart Valves By Value
    3. Ventricular Assist Devices
      1. Ventricular Assist Devices By Value
    4. Cardiac Pacemakers & ICDs
      1. Cardiac Pacemakers & ICDs By Value
  3. Artificial Kidney
    1. By Value
  4. Artificial Pancreas
    1. By Value
  5. Artificial Lungs/ECMO
    1. By Value
  6. Cochlear & Auditory Brain-stem Implants
    1. By Value
  7. Bio-artificial Liver
    1. By Value
  8. Other Organ Types
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Mechanical
    1. By Value
  3. Electronic/Bionics
    1. By Value
  4. Wearable/Externally Worn
    1. By Value
  5. 3D-bioprinted Constructs
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Hospitals
    1. By Value
  3. Ambulatory Surgical Centers
    1. By Value
  4. Other End Users
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Artificial Organs Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Medtronic
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Abbott
Boston Scientific Corp.
Johnson and Johnson Services Inc.
SynCardia Systems LLC
Berlin Heart GmbH
Koninklijke Philips N.V.
Jarvik Heart Inc.
BiVACOR Pty Ltd
Terumo Corp.
Getinge AB
Fresenius Medical Care AG
AWAK Technologies Pte Ltd
ALung Technologies Inc.
Cochlear Ltd.
Asahi Kasei Medical Co. Ltd
Braun Melsungen AG

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment